Alvograstim

Alvograstim Overdosage

filgrastim

Manufacturer:

Distributor:

Marketer:

Mega Lifesciences

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Overdosage

The effects of filgrastim overdose have not been established. Discontinuation of filgrastim therapy usually results in a 50% decrease in circulating neutrophils within 1 to 2 days, with a return to normal levels in 1 to 7 days.

Asia's one-stop resource for medical news, clinical reference and education

Already a member? Sign in